Renal transport of uric acid: evolving concepts and uncertainties.

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol (2013) 1.15

Linking uric acid metabolism to diabetic complications. World J Diabetes (2014) 0.90

Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy. Adv Ther (2015) 0.90

Pathophysiological and physicochemical basis of ammonium urate stone formation in dolphins. J Urol (2014) 0.83

Predicting allopurinol response in patients with gout. Br J Clin Pharmacol (2015) 0.83

Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase. Cell (2017) 0.82

Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease. BMC Nephrol (2014) 0.82

Association between Dietary Magnesium Intake and Hyperuricemia. PLoS One (2015) 0.80

Association of a polymorphism in a gene encoding a urate transporter with CKD progression. Clin J Am Soc Nephrol (2014) 0.78

Gout: An old disease in new perspective - A review. J Adv Res (2017) 0.78

Natural Products Improving Hyperuricemia with Hepatorenal Dual Effects. Evid Based Complement Alternat Med (2016) 0.77

[Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency]. Z Rheumatol (2015) 0.77

Time to target uric acid to retard CKD progression. Clin Exp Nephrol (2016) 0.77

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study). Ann Rheum Dis (2016) 0.77

Catalysis and Structure of Zebrafish Urate Oxidase Provide Insights into the Origin of Hyperuricemia in Hominoids. Sci Rep (2016) 0.76

Potential causal associations between vitamin D and uric acid: Bidirectional mediation analysis. Sci Rep (2015) 0.76

Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers. Drug Des Devel Ther (2016) 0.75

Aldose reductase mediates endothelial cell dysfunction induced by high uric acid concentrations. Cell Commun Signal (2017) 0.75

Recent advances in understanding and managing gout. F1000Res (2017) 0.75

Paracellular route is the major urate transport pathway across the blood-placental barrier. Physiol Rep (2014) 0.75

Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1. BMJ Open (2015) 0.75

Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study. Drug Des Devel Ther (2016) 0.75

Genetic variation underlying renal uric acid excretion in Hispanic children: the Viva La Familia Study. BMC Med Genet (2017) 0.75

A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties. PLoS One (2016) 0.75

Hyperuricemia after orthotopic liver transplantation: divergent associations with progression of renal disease, incident end-stage renal disease, and mortality. BMC Nephrol (2017) 0.75

Is Uric Acid a Missing Link between Previous Gestational Diabetes Mellitus and the Development of Type 2 Diabetes at a Later Time of Life? PLoS One (2016) 0.75

Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy. World J Diabetes (2015) 0.75

Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association. Curr Hypertens Rep (2017) 0.75

Characterisation of risk factors for stones in hyperuricosuric men attending a stone clinic. Urolithiasis (2014) 0.75

Physiological functions and pathogenic potential of uric acid: A review. J Adv Res (2017) 0.75

Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J Adv Res (2016) 0.75

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial. J Adv Res (2017) 0.75

Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43

Molecular identification of a danger signal that alerts the immune system to dying cells. Nature (2003) 8.90

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A (1981) 8.45

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet (2008) 7.33

A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet (2008) 5.93

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature (2002) 5.62

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA (2008) 5.59

Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet (2009) 4.97

SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet (2008) 4.67

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res (2001) 4.05

Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A (1989) 4.02

The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet (2007) 3.21

Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A (2009) 3.13

Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension (2002) 2.47

Uric acid transport and disease. J Clin Invest (2010) 2.33

Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med (2009) 2.25

Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol (2005) 2.24

Uric acid: A marker of increased cardiovascular risk. Atherosclerosis (2008) 2.23

Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet (2008) 2.21

Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem (2004) 2.18

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) (2004) 2.13

Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem (2008) 2.09

Regulation of renal urate excretion: a critical review. Am J Kidney Dis (1998) 2.00

Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol (2002) 2.00

The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol (2002) 1.94

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A (1994) 1.88

Cloning and expression of cDNA for a Na/Pi cotransport system of kidney cortex. Proc Natl Acad Sci U S A (1991) 1.84

Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int (2002) 1.78

Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids (2008) 1.76

Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics (2000) 1.72

A 1.1-Mb transcript map of the hereditary hemochromatosis locus. Genome Res (1997) 1.71

The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int (2007) 1.68

Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol (2005) 1.66

Tubular secretion of urate in man. J Clin Invest (1959) 1.60

Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem (2000) 1.60

Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol (2007) 1.60

Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol (2005) 1.59

Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun (2012) 1.58

Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics (2008) 1.53

Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol (2009) 1.52

Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci (2004) 1.52

Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem (2004) 1.46

A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther (2006) 1.43

Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol (2004) 1.34

A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Hum Mol Genet (2010) 1.33

Regulation of phosphate transport in proximal tubules. Pflugers Arch (2008) 1.33

Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem (2008) 1.26

Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet (2009) 1.25

Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci U S A (2009) 1.23

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proc Natl Acad Sci U S A (2010) 1.23

The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology (Oxford) (2010) 1.20

Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep (2012) 1.19

Localization of NaPi-1, a Na/Pi cotransporter, in rabbit kidney proximal tubules. II. Localization by immunohistochemistry. Pflugers Arch (1993) 1.16

Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis (2009) 1.16

Molecular cloning of the cDNA encoding a human renal sodium phosphate transport protein and its assignment to chromosome 6p21.3-p23. Genomics (1993) 1.15

Mouse GLUT9: evidences for a urate uniporter. Am J Physiol Renal Physiol (2009) 1.15

Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem (2003) 1.14

Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet (2011) 1.13

Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol (2004) 1.11

c/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. J Biol Chem (2006) 1.09

Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem (2010) 1.09

Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol (2001) 1.08

Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese. Clin Genet (2008) 1.08

The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08

T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc Natl Acad Sci U S A (2011) 1.07

Osmoregulation in amphibians and reptiles. Annu Rev Physiol (1977) 1.06

Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem (2010) 1.03

Molybdenum and tungsten enzymes: the xanthine oxidase family. Curr Opin Chem Biol (2006) 1.02

Evidence for a postsecretory reabsorptive site for uric acid in man. J Clin Invest (1973) 1.02

Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem Biophys Res Commun (2003) 1.01

Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PLoS One (2012) 1.01

Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res (1998) 1.00

Uric acid excretion in normal children. J Pediatr (1978) 1.00

Origin and extrarenal elimination of uric acid in man. Nephron (1975) 1.00

Increased power of mixed models facilitates association mapping of 10 loci for metabolic traits in an isolated population. Hum Mol Genet (2010) 0.98

Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis (2003) 0.97

Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. J Clin Endocrinol Metab (2005) 0.97

Generation and characterization of sodium-dicarboxylate cotransporter-deficient mice. Kidney Int (2007) 0.96

Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice. J Biol Chem (2008) 0.96

Identification of a new member of type I Na/phosphate co-transporter in the rat kidney. Nephron Physiol (2003) 0.95

Molecular cloning and functional reconstitution of a urate transporter/channel. J Biol Chem (1997) 0.93

Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int (2003) 0.91

Kidney-specific expression of a novel mouse organic cation transporter-like protein. FEBS Lett (1997) 0.90

Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. Am J Physiol Renal Physiol (2011) 0.90

Urate transporters: an evolving field. Semin Nephrol (2011) 0.90

Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney. Biochim Biophys Acta (2007) 0.87

Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2. Nephrol Dial Transplant (2011) 0.86

Paradoxical effects of pyrazinoate and nicotinate on urate transport in dog renal microvillus membranes. J Clin Invest (1985) 0.86

Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. J Clin Invest (2001) 0.83

Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2). Nucleosides Nucleotides Nucleic Acids (2011) 0.81

New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond. Curr Rheumatol Rep (2010) 0.79

Fractional excretion of uric acid in infancy and childhood. Index of tubular maturation. Arch Dis Child (1974) 0.79

Indirect coupling to Na+ of p-aminohippuric acid uptake into rat renal basolateral membrane vesicles. Am J Physiol (1987) 0.79

Establishment and analysis of SLC22A12 (URAT1) knockout mouse. Nucleosides Nucleotides Nucleic Acids (2010) 0.79

Maturational changes in renal tubular transport. Curr Opin Nephrol Hypertens (2003) 0.79

Expression of the urate transporter/channel is developmentally regulated in human kidneys. Am J Physiol Renal Physiol (2001) 0.77

The chemistry of urinary stones around 1800: a first in clinical chemistry. Kidney Int (1995) 0.77

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50

Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol (2010) 4.59

Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J (2010) 2.91

The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int (2004) 2.89

Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int (2010) 2.50

Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int (2010) 2.35

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A (2009) 2.23

Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol (2007) 2.02

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int (2012) 1.82

Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int (2002) 1.78

Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol (2013) 1.78

Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int (2003) 1.76

Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71

Albumin regulates the Na+/H+ exchanger 3 in OKP cells. J Am Soc Nephrol (2003) 1.67

Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol (2006) 1.66

Klotho: a novel regulator of calcium and phosphorus homeostasis. Pflugers Arch (2011) 1.63

Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol (2011) 1.57

Cloning and characterization of the human soluble adenylyl cyclase. Am J Physiol Cell Physiol (2005) 1.54

Hypercalciuria associated with high dietary protein intake is not due to acid load. J Clin Endocrinol Metab (2011) 1.54

Circadian variation in urine pH and uric acid nephrolithiasis risk. Nephrol Dial Transplant (2007) 1.51

Etiological role of estrogen status in renal stone formation. J Urol (2002) 1.48

Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int (2003) 1.46

Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44

Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol (2010) 1.41

Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol (2013) 1.40

Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis. Am J Physiol Renal Physiol (2005) 1.31

Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol (2008) 1.27

The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int (2013) 1.27

Lipid- and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods. Proc Natl Acad Sci U S A (2004) 1.23

Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch (2008) 1.21

Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol (2002) 1.20

Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens (2004) 1.20

Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis (2006) 1.19

Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system. Mol Cell Proteomics (2008) 1.18

Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int (2004) 1.18

Secreted klotho and chronic kidney disease. Adv Exp Med Biol (2012) 1.13

Role of c-SRC and ERK in acid-induced activation of NHE3. Kidney Int (2002) 1.13

Nephrolithiasis in children. Pediatr Nephrol (2005) 1.12

Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol (2004) 1.11

Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int (2003) 1.11

Klotho and chronic kidney disease. Contrib Nephrol (2013) 1.11

Ontogeny of NHE8 in the rat proximal tubule. Am J Physiol Renal Physiol (2007) 1.10

Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol (2013) 1.09

The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant (2012) 1.08

A sperm-specific Na+/H+ exchanger (sNHE) is critical for expression and in vivo bicarbonate regulation of the soluble adenylyl cyclase (sAC). Proc Natl Acad Sci U S A (2007) 1.08

Steady-state function of the ubiquitous mammalian Na/H exchanger (NHE1) in relation to dimer coupling models with 2Na/2H stoichiometry. J Gen Physiol (2008) 1.07

Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. Am J Physiol Renal Physiol (2009) 1.07

Na+/H+ exchangers in renal regulation of acid-base balance. Semin Nephrol (2006) 1.06

Klotho as a potential biomarker and therapy for acute kidney injury. Nat Rev Nephrol (2012) 1.06

Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences. Clin J Am Soc Nephrol (2011) 1.06

Na+/H+ exchangers: physiology and link to hypertension and organ ischemia. Curr Opin Nephrol Hypertens (2005) 1.05

Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin. Am J Physiol Renal Physiol (2006) 1.04

Renal and extrarenal actions of Klotho. Semin Nephrol (2013) 1.04

Characterization of the sodium/hydrogen exchanger NHA2. J Am Soc Nephrol (2008) 1.02

Nephrolithiasis in topiramate users. Urol Res (2010) 1.01

Shank2 associates with and regulates Na+/H+ exchanger 3. J Biol Chem (2005) 1.01

Acute regulation of Na/H exchanger NHE3 by adenosine A(1) receptors is mediated by calcineurin homologous protein. J Biol Chem (2003) 1.00

Postpneumonectomy lung expansion elicits hypoxia-inducible factor-1alpha signaling. Am J Physiol Lung Cell Mol Physiol (2007) 1.00

Characterization of Na+/H+ exchanger NHE8 in cultured renal epithelial cells. Am J Physiol Renal Physiol (2007) 1.00

Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis. Nephrol Dial Transplant (2004) 0.98

Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hypertens (2006) 0.98

Dual role of citrate in mammalian urine. Curr Opin Nephrol Hypertens (2006) 0.97

Expression of epidermal growth factor and surfactant proteins during postnatal and compensatory lung growth. Am J Physiol Lung Cell Mol Physiol (2002) 0.96

Klotho and kidney disease. J Nephrol (2010) 0.95

The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol (2004) 0.92

OKP cells express the Na-dicarboxylate cotransporter NaDC-1. Am J Physiol Cell Physiol (2004) 0.91

Calcineurin homologous protein: a multifunctional Ca2+-binding protein family. Am J Physiol Renal Physiol (2011) 0.91

Regulated expression of hypoxia-inducible factors during postnatal and postpneumonectomy lung growth. Am J Physiol Lung Cell Mol Physiol (2005) 0.90

Phosphatonins: a new class of phosphate-regulating proteins. Curr Opin Nephrol Hypertens (2002) 0.89

The calcineurin homologous protein-1 increases Na(+)/H(+) -exchanger 3 trafficking via ezrin phosphorylation. J Am Soc Nephrol (2009) 0.89

Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase. J Cell Physiol (2009) 0.88

The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers. Kidney Int (2012) 0.88

Effect of claudins 6 and 9 on paracellular permeability in MDCK II cells. Am J Physiol Regul Integr Comp Physiol (2008) 0.87

PiT-2 coming out of the pits. Am J Physiol Renal Physiol (2009) 0.87

Expression and role of serum and glucocorticoid-regulated kinase 2 in the regulation of Na+/H+ exchanger 3 in the mammalian kidney. Am J Physiol Renal Physiol (2010) 0.87

Upregulation of erythropoietin receptor during postnatal and postpneumonectomy lung growth. Am J Physiol Lung Cell Mol Physiol (2004) 0.85

SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis. J Am Soc Nephrol (2013) 0.85

Proximal tubule Na+/H+ exchanger activity in adult NHE8-/-, NHE3-/-, and NHE3-/-/NHE8-/- mice. Am J Physiol Renal Physiol (2012) 0.84

Synergistic upregulation of erythropoietin receptor (EPO-R) expression by sense and antisense EPO-R transcripts in the canine lung. Proc Natl Acad Sci U S A (2008) 0.84

Subclinical celiac disease and crystal-induced kidney disease following kidney transplant. Am J Kidney Dis (2012) 0.83

Molecular aspects of acute inhibition of Na(+)-H(+) exchanger NHE3 by A(2)-adenosine receptor agonists. J Physiol (2002) 0.82

Mechanism of urinary calcium regulation by urinary magnesium and pH. J Am Soc Nephrol (2008) 0.82

Acute regulation of renal Na+/H+ exchanger NHE3 by dopamine: role of protein phosphatase 2A. Am J Physiol Renal Physiol (2010) 0.82

Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation. Am J Physiol Renal Physiol (2004) 0.82

Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis. Kidney Int (2008) 0.82

Hypothesizing on the evolutionary origins of salt-induced hypercalciuria. Curr Opin Nephrol Hypertens (2005) 0.81

Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis. J Urol (2005) 0.81

GABARAP deficiency modulates expression of NaPi-IIa in renal brush-border membranes. Am J Physiol Renal Physiol (2009) 0.80

Recurrent calcium nephrolithiasis associated with primary aldosteronism. Am J Kidney Dis (2004) 0.80

Chronic regulation of the renal Na(+)/H(+) exchanger NHE3 by dopamine: translational and posttranslational mechanisms. Am J Physiol Renal Physiol (2013) 0.80

Comparison of semi-empirical and computer derived methods for estimating urinary saturation of brushite. J Urol (2009) 0.80

When EGF is offside, magnesium is wasted. J Clin Invest (2007) 0.79

Fibroblast growth factor 23: friend or foe in uremia? J Clin Invest (2012) 0.78

Scaffolds: Orchestrating proteins to achieve concerted function. Kidney Int (2003) 0.78

αKlotho and vascular calcification: an evolving paradigm. Curr Opin Nephrol Hypertens (2014) 0.78

Clinical assessment of phosphorus status, balance and renal handling in normal individuals and in patients with chronic kidney disease. Curr Opin Nephrol Hypertens (2013) 0.77

Biochemical and histological assessment of alkali therapy during high animal protein intake in the rat. Bone (2009) 0.77

Glucocorticoid-mediated hypertension: does the vascular smooth muscle hold all the answers? J Am Soc Nephrol (2008) 0.77

Bicarbonate reabsorption and NHE-3 expression: abundance and activity are increased in Henle's loop of remnant rats. Kidney Int (2002) 0.76